Porter, Ross JohnMurray, GraemeAlnabulsi, AbdoHumphries, Matthew PJames, Jacqueline ASalto-Tellez, ManuelCraig, Stephanie G.Wang, Ji MingYoshimura, TeizoMcLean, Mairi2021-09-252021-09-252021-09-01Porter, R J, Murray, G, Alnabulsi, A, Humphries, M P, James, J A, Salto-Tellez, M, Craig, S G, Wang, J M, Yoshimura, T & McLean, M 2021, 'Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate', The Journal of Pathology. Clinical Research, vol. 7, no. 5, pp. 495-506. https://doi.org/10.1002/cjp2.2222056-4538ORCID: /0000-0003-3981-2420/work/94083243ORCID: /0000-0002-7443-2653/work/94084010https://hdl.handle.net/2164/17174ACKNOWLEDGEMENTS: We wish to acknowledge the Grampian Tissue Biorepository for assistance in tissue preparation and immunohistochemistry, and also Daniel Brice and Susan Berry for their help with the organoid model. This study was funded in part by The Carnegie Trust for the Universities of Scotland and British Society for Immunology (studentship awards to RJP within the MHM laboratory).121176696engSDG 3 - Good Health and Well-beingcolorectal cancerLL-37cathelicidinorganoidlymphocytesR MedicineOtherSupplementary DataSupplementary InformationRColonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrateJournal article10.1002/cjp2.22275